Abstract
Despite the success of 99mTc-sestamibi and 99mTc-tetrofosmin, the search for 99mTc heart imaging agents having a pharmacokinetic behavior much closer to that of an ideal perfusion tracer has been never interrupted. This short review illustrates advances in this field that have been made using the class of 99mTc complexes characterized by the presence of a terminal technetium-nitrogen multiple bond. This category of 99mTc compounds has proven to be particularly useful for cardiac imaging and a number of highly interesting compounds have been developed. The main chemical and biological properties of these agents are briefly summarized here.
Keywords: Myocardial imaging, Myocardial perfusion, 99mTc nitrido complexes, SPECT
Current Radiopharmaceuticals
Title: The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging
Volume: 2 Issue: 4
Author(s): Adriano Duatti, Shuang Liu and Roberto Pasqualini
Affiliation:
Keywords: Myocardial imaging, Myocardial perfusion, 99mTc nitrido complexes, SPECT
Abstract: Despite the success of 99mTc-sestamibi and 99mTc-tetrofosmin, the search for 99mTc heart imaging agents having a pharmacokinetic behavior much closer to that of an ideal perfusion tracer has been never interrupted. This short review illustrates advances in this field that have been made using the class of 99mTc complexes characterized by the presence of a terminal technetium-nitrogen multiple bond. This category of 99mTc compounds has proven to be particularly useful for cardiac imaging and a number of highly interesting compounds have been developed. The main chemical and biological properties of these agents are briefly summarized here.
Export Options
About this article
Cite this article as:
Duatti Adriano, Liu Shuang and Pasqualini Roberto, The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging, Current Radiopharmaceuticals 2009; 2 (4) . https://dx.doi.org/10.2174/1874471010902040268
DOI https://dx.doi.org/10.2174/1874471010902040268 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company
Current Drug Safety Role of Polyphenols in Diet and Nutrition-An Updated Review
Current Nutrition & Food Science Pleiotropic Effects of Omega-3 Fatty Acids
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Eplerenone, a New Selective Aldosterone Blocker
Current Pharmaceutical Design Possibility of Enhanced Risk of Retinal Angiogenesis in Athletes with Pre- Existing Retinal Situation Abusing Erythropoietin Doping: A Hypothesis
Current Drug Safety Tako-tsubo Cardiomyopathy: A Review of the Literature
Current Cardiology Reviews Epigenetic Mechanisms in Alzheimer's Disease
Current Medicinal Chemistry GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews Employment of Quality by Design Approach via Response Surface Methodology to Optimize and Develop Modified-release Formulation of Hydrochlorothiazide
Current Computer-Aided Drug Design Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Chemistry, Physiology, and Pharmacology of β-Adrenergic Mechanisms in the Heart. Why are β-Blocker Antiarrhythmics Superior?
Current Pharmaceutical Design High Serum Alkaline Phosphatase Levels in Relation to Multi-Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial
Current Vascular Pharmacology Antibiotic Susceptibility Evaluation of Bacterial Agents Causing Infection in Children with Acute Tonsillopharyngitis
Infectious Disorders - Drug Targets Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Mitochondria Sentencing About Cellular Life and Death: A Matter of Oxidative Stress
Current Pharmaceutical Design Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews